- £19.48m
- £18.57m
- £1.92m
- 84
- 48
- 39
- 60
Annual income statement for Develop North, fiscal year end - November 30th, GBP millions except per share, conversion factor applied.
2020 November 30th | 2021 November 30th | 2022 November 30th | 2023 November 30th | 2024 November 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.89 | 1.7 | 1.41 | 1.55 | 1.92 |
Cost of Revenue | |||||
Gross Profit | 1.84 | 1.63 | 1.34 | 1.49 | 1.86 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.807 | 0.767 | 0.763 | 1.14 | 0.667 |
Operating Profit | 1.09 | 0.93 | 0.646 | 0.416 | 1.25 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 0.856 | 0.929 | 0.514 | 0.261 | 1.17 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.856 | 0.929 | 0.514 | 0.261 | 1.17 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.856 | 0.929 | 0.514 | 0.261 | 1.17 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.856 | 0.929 | 0.514 | 0.261 | 1.17 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.041 | 0.042 | 0.025 | 0.03 | 0.051 |
Dividends per Share |